Concept Richtlijn Erfelijke darmkanker 2007 versie 7 - Oncoline

17. Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrialcancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction forascertainment. J Med Genet. 2005;42:491-6.18. Schmeler KM, Lynch HT, Chen L-M, Munsell MF, Soliman PT, Clark MB et al.Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynchsyndrome. NEngl J Med 2006;354:261-9.19. Scott RJ, Mc Phillips M, Meldrum CJ, Fitzgerald PE, Adams K, Spigelman AD et al.Hereditary nonpolyposis colorectal cancer in 95 families: differences and similaritiesbetween mutation-positive and mutation-negative kindreds. Am J Hum Genet2001;68:118-27.20. Scott RH, Homfray T, Huxter NL. Familial T-cell non-Hodgkin lymphoma caused bybiallelic MSH2 mutations. J Med Genet 2007;44:e83.21. Vasen HF, Wijnen JT, Menko FH, Kleibeuker JH. Taal BG, Griffioen G et al. Cancer riskin families with hereditary nonpolyposis colorectal cancer diagnosed by mutationanalysis. Gastroenterology 1996;110:1020-7.22. Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G et al.MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a studyof hereditary nonpolyposis colorectal cancer families. J Clin Oncol 2001;19:4074-80.23. Watson P, Lynch HT. Cancer risk in mismatch repair gene mutation carriers. Fam Cancer2001;1:57-60.24. Welkenhuysen M, Evers-Kieboom, G. d’Ydewalle G. The language of uncertainty ingenetic risk communication: framing and verbal versus numerical information. PatientEduc. Couns. 2001;43:179-87.25. Signalerings Commissie Kanker van KWF Kankerbestrijding. De rol van voeding bij hetontstaan van kanker. KWF Kankerbestrijding 2004.Concept landelijke richtlijn erfelijke darmkanker versie 7 d.d. 7 november 2007.53